MEDS5009 CASE STUDY EXAM Flashcards
(79 cards)
small pouch-like bulge or pocket that can appear anywhere along GIT
symptoms: pain and tenderness in lower left quadrant, nausea and vomiting, fever, elevated WBC count, diarrhoea, flatulence, bloating, abdominal pain, cramps, weight loss, weakness
Diverticulum
Occurs as a result of backward flow of gastric contents into oesophagus
caused: increase in gastric volume and intra-abdominal pressure, lowered tone of oesophageal sphincter
symptoms: dyspepsia, regurgitation, hypersalivation, dysphagia, chronic cough, asthma, chest pain, flatulence, bloating, nausea, vomiting
Gastroesophageal reflux disease (GERD)
inflammation of stomach and stomach lining characterised by absence of grossly visible erosions and presence of chronic inflammatory changes, and eventually atrophy of glandular epithelium of stomach
causes: NSAIDS, H.pylori, alcohol
symptoms: vomiting, pain, nausea
complication: ulcer formation
Gastritis
sore that develops in lining of stomach and duodenum
causes: NSAIDS, H.pylori infection
symptoms: abdominal pain (at night, relieved by antacids, occur 2-3 hours after meal), nausea, indigestion, vomiting blood, blood in stool// black stool, weight loss, fatigue
complications: hemorrhage, obstruction, perforation
Peptic Ulcer
recurrent, granulomatous type of inflammatory response that can affect any area along GIT (mainly ileum, colon), characterised by skip lesions
symptoms: diarrhoea, fistulas, strictures, perianal abscesses complications: malabsorption
Crohn’s Disease
non-specific continuous inflammatory condition of colon
symptoms: diarrhoea, rectal bleeding
complications: development of cancer
ulcerative colitis
normal CRP
< 10 mg/L
decrease in bile flow through canaliculi and reduction in secretion of water, bilirubin, bile acids from hepatocytes
complications: fatty changes, destruction of CT, accumulation of bile products and debris, fibrosis, biliary cirrhosis
cholestasis
yellow discolouration of skin and deep tissues as result of high levels of bilirubin in blood, due to imbalance between production and excretion
jaundice
RBC destruction in excess of capacity of liver
elevated unconjugated bilirubin, normal stool colour
pre-jaundice
impaired capacity of liver to remove bilirubin from blood and conjugate it
elevated conjugated and unconjugated bilirubin, dark urine, elevated serum alkaline phosphatase
intra-jaundice
bile flow obstructed at any point between hepatic duct and intestine
elevated conjugated bilirubin, grey stool, dark urine, elevated serum alkaline phosphatase
post-jaundice
single stranded RNA virus transmitted through fecal oral route (contaminated food and water)
symptoms: fever, nausea, malaise, abdominal discomfort, dark urine, jaundice
last 2 months, no carrier or chronic status, vaccine
hepatitis A
double stranded DNA virus transmitted through blood or serum (sexual or oral contact)
carrier status and chronic, vaccine
hepatitis B
single strand RNA virus which is the most common cause of chronic hepatitis, cirrhosis and cancer
transmitted by high risk drug use and sexual behaviour
no vaccine
complications: fibrosis leading to cirrhosis, end-stage liver disease, hepatocellular cancer
hepatitis C
chronic inflammatory reaction of liver lasting more than 3 months characterised by elevated liver enzymes
symptoms: fatigue, malaise, loss fo appetite, jaundice
chronic viral hepatitis
surpass the capacity of the liver to metabolise alcohol, resulting in the by-products of alcohol metabolism contributing to liver damage
stages: simple steatosis, alcoholic hepatitis, cirrhosis
alcohol liver disease
metabolic dysfunction affecting liver, lipid accumulation within hepatocytes and formation of free radicals
stages: simple steatosis (over-nutrition), non-alcoholic hepatitis, cirrhosis
non-alcoholic fatty liver disease
normal ALT
<35 U/L, test for hepatocellular injury
normal AST
<40 U/L, test for hepatocellular injury
GGT
alcohol abuse identification
serum albumin and prothrombin time
reflect liver synthetic capacity
ALP and GGT
cholestatic bile flow markers
normal serum albumin
3.5 - 5.5 g/dL